PACIRA BIOSCIENCES, INC.

(PCRX)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 08-08-2022
58.51 USD   -0.65%
04/08PACIRA BIOSCIENCES, INC. : RBC Capital Markets ontvangt een koopadvies
MM
03/08Pacira BioSciences Q2 Non-GAAP EPS daalt, inkomsten stijgen
MT
03/08Winstflits (PCRX) PACIRA BIOSCIENCES boekt Q2 inkomsten $169,4M
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op PACIRA BIOSCIENCES, INC.
03/08PACIRA BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
03/08Pacira BioSciences Q2 Non-GAAP EPS Drops, Revenue Rises
03/08TRANSCRIPT : Pacira BioSciences, Inc., Q2 2022 Earnings Call, Aug 03, 2022
03/08PACIRA BIOSCIENCES : Reports Second Quarter 2022 Financial Results - Form 8-K
03/08PACIRA : Q2 Earnings Snapshot
03/08Pacira BioSciences Reports Second Quarter 2022 Financial Results
03/08Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q2 Revenue $169.4M
03/08Pacira BioSciences Reports Second Quarter 2022 Financial Results
03/08Earnings Flash (PCRX) PACIRA BIOSCIENCES Reports Q2 EPS $0.51
03/08Pacira BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months..
02/08Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthca..
02/08Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthca..
27/07Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022
27/07Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022
14/07PACIRA BIOSCIENCES : Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million - F..
14/07Pacira BioSciences Reports Higher Preliminary Q2 Revenue
14/07Pacira Biosciences, Inc. Not to Provide Revenue Guidance for the Fiscal Year 2022
14/07Pacira BioSciences Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million
14/07Pacira BioSciences Reports Revenues Results for the Second Quarter of 2022
16/06National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Prog..
16/06National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Prog..
14/06PACIRA BIOSCIENCES : Reports Preliminary Net Product Sales for EXPAREL and ioveraį of $46...
14/06Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and ioveraį of†$46..
14/06Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and ioveraį of†$46..
10/06PACIRA BIOSCIENCES, INC. : Change in Directors or Principal Officers, Submission of Matter..
09/06INSIDER SELL : Pacira Biosciences
09/06INSIDER SELL : Pacira Biosciences
02/06Pacira BioSciences to Participate in Fireside Chat at the Jefferies Healthcare Conferen..
25/05Pacira BioSciences and the National Senior Games Association Break a GUINNESS WORLD REC..
12/05Pacira BioSciences Posts Higher Exparel, Lower Iovera Sales in April
12/05Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and ioveraį of $45..
10/05Pacira BioSciences to Present at Two Healthcare Conferences in May
10/05Pacira BioSciences to Present at Two Healthcare Conferences in May
10/05Genascence Corporation announced that it expects to receive funding from Pacira BioScie..
04/05PACIRA BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
04/05Pacira BioSciences Q1 Non-GAAP EPS, Revenue Higher
04/05TRANSCRIPT : Pacira BioSciences, Inc., Q1 2022 Earnings Call, May 04, 2022
04/05PACIRA : Q1 Earnings Snapshot
04/05PACIRA BIOSCIENCES, INC. : Results of Operations and Financial Condition, Change in Direct..
04/05Pacira BioSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31,..
04/05Pacira BioSciences, Inc. Promotes Daryl Gaugler as Chief Operating Officer
04/05Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q1 Revenue $158M, vs. Street Est of $155..
04/05Pacira BioSciences Reports First Quarter 2022 Financial Results
04/05Pacira BioSciences Reports First Quarter 2022 Financial Results
27/04Pacira to Report First Quarter 2022 Financial Results on Wednesday May 4, 2022
25/04INSIDER SELL : Pacira BioSciences
21/04INSIDER SELL : Pacira Biosciences
12/04Pacira BioSciences Reports Increased Preliminary Revenue for Q1
12/04PACIRA BIOSCIENCES : Reports Preliminary Revenues of $157.4 to $158.4 Million for the Firs..
12/04Pacira BioSciences Reports Preliminary Revenues of $157.4 to $158.4 Million for the Fir..
12/04Pacira BioSciences, Inc. Provides Preliminary Revenue Guidance for the First Quarter of..
12/04Pacira BioSciences, Inc. Announces Net Product Sales for the Month and First Quarter of..
11/04CarthroniX, Inc. announced that it has received $2.25 million in funding from Pacira Bi..
08/04INSIDER SELL : Pacira BioSciences
05/04Pacira BioSciences to Participate in Fireside Chat at the 21st Annual Needham Virtual H..
24/03Spine BioPharma, LLC announced that it has received $12.999998 million in funding from ..
23/03INSIDER SELL : Pacira BioSciences
16/03TRANSCRIPT : Pacira BioSciences, Inc. Presents at Barclays Global Healthcare Conference 20..
15/03Pacira BioSciences Logs Higher Exparel, Ioveradegree Sales in February
15/03PACIRA BIOSCIENCES : Reports Preliminary Net Product Sales for EXPAREL and ioveraį of $42...
15/03Pacira Biosciences, Inc. Announces Preliminary Unaudited Net Product Sales for the Mont..
15/03Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and ioveraį of $4..
09/03Pacira BioSciences to Participate in Fireside Chat at the Barclays Global Healthcare Co..
28/02PACIRA BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition a..
24/02Pacira Biosciences Posts Higher Q4 Adjusted Earnings, Revenue
24/02PACIRA : Q4 Earnings Snapshot
24/02TRANSCRIPT : Pacira BioSciences, Inc., Q4 2021 Earnings Call, Feb 24, 2022
24/02PACIRA BIOSCIENCES : Reports Full-Year and Fourth Quarter 2021 Financial Results - Form 8-..
24/02Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q4 Revenue $159.2M, vs. Street Est of $1..
24/02Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q4 EPS $0.99, vs. Street Est of $0.83
24/02Pacira BioSciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December..
24/02Pacira BioSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, ..
24/02Pacira BioSciences Reports Full-Year and Fourth Quarter 2021 Financial Results
16/02Pacira to Report 2021 Financial Results on Thursday February 24, 2022
15/02PACIRA BIOSCIENCES : Reports Preliminary Net Product Sales for EXPAREL and ioveraį of $37...
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op PACIRA BIOSCIENCES, INC.